Prevention of hepatotoxicity but loss of antimelanoma effect with combined fotemustine and anti-oxidant treatment [2]

Internal Medicine Journal

Volumn 34, Issue 5, 2004, Pages 298-299

  Webster, G J M ^a   Kurtovic, J ^a   Singh Grewal, I ^a   Friedlander, M ^a   Riordan, S M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLOROETHYL DIAZOHYDROXIDE; ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; ANTIOXIDANT; DIETHYLPHOSPHONATE ISOCYANATE; DRUG METABOLITE; FOTEMUSTINE; UNCLASSIFIED DRUG;

ADULT; ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MECHANISM; FEMALE; FOLLOW UP; HEADACHE; HUMAN; HYSTERECTOMY; LETTER; LIVER FUNCTION TEST; LIVER PROTECTION; LIVER TOXICITY; LUNG METASTASIS; MELANOMA; PRIORITY JOURNAL; PROPHYLAXIS; TREATMENT OUTCOME; TUMOR BIOPSY; VISCERAL METASTASIS;

ACETYLCYSTEINE; ADULT; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BRAIN NEOPLASMS; FEMALE; HEPATITIS, TOXIC; HUMANS; LIVER; LUNG NEOPLASMS; MELANOMA; NITROSOUREA COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS; TREATMENT OUTCOME;

EID: 2942592680     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1444-0903.2004.00598.x     Document Type: Letter

References (6)

1. Jacquillat C, Khayat D, Banzet P, Weil M, Fumoleau P, Avril MF et al. Final report of the French multicentric phase II study of the nitrosurea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastasis. Cancer 1990; 66: 1873-8.
2. Brakenhoff JP, Commandeur JN, Wormhoudt LW, Groot EJ, Vermeulen NP. Molecular mechanisms of toxic effects of fotemustine in rat hepatocytes and subcellular rat liver fractions. Carcinogenesis 1996; 17: 715-24.
3. Vermeulen NP, Commandeur JN, Groot EJ, Wormhoudt LW, Ramnatshing S, Li QJ et al. Toxicity of fotemustine in rat hepatocytes and mechanism-based protection against it. Chem Biol Interact 1998; 110: 139-58.
4. del Olmo M, Alonso-Varona A, Castro B, Calle Y, Bilbao P, Palomares T. Effects of L-2-oxothiazolidine-4-carboxylate on the cytotoxic activity and toxicity of cyclophosphamide in mice bearing B16F10 melanoma liver metastases. Melanoma Res 2000; 10: 103-12.
5. Morgan LR, Donley PJ, Harrison EF, Hunter HL. Protective effect of N-acetylcysteine on the urotoxicity produced by oxazaphosphorine without interference with anticancer activity. Eur J Cancer Clin Oncol 1982; 18: 113-14.
6. Vickers AJ, Cassileth BR. Unconventional therapies for cancer and cancer-related symptoms. Lancet Oncol 2001; 2: 226-32.